Sunshine Biopharma Inc. (SBFM) Operating income 2016–2025
Sunshine Biopharma Inc. (SBFM) annual operating income history from SEC filings — each fiscal year as reported.
-$6.2MFY2025 · since FY2016: -$993,108 → -$6.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$6.2M | -7.1% |
| FY2024 | -$5.8M | -21.5% |
| FY2023 | -$4.8M | +82.3% |
| FY2022 | -$27.0M | -1006.5% |
| FY2021 | -$2.4M | -323.0% |
| FY2020 | -$576,874 | +10.1% |
| FY2019 | -$641,636 | +44.9% |
| FY2018 | -$1.2M | -35.8% |
| FY2017 | -$857,190 | +13.7% |
| FY2016 | -$993,108 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SBFM financial trends
SBFM RevenueSBFM Net incomeSBFM Net marginSBFM Gross profitSBFM Gross marginSBFM Operating marginSBFM Operating cash flowSBFM Free cash flowSBFM Capital expendituresSBFM Return on equitySBFM Stock buybacksSBFM Dividends paidSBFM Total assetsSBFM Total liabilitiesSBFM Shareholders’ equitySBFM overview →